Independent Advisor Alliance »

Neurosense Therapeutics shares owned by Independent Advisor Alliance

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Independent Advisor Alliance from 13F filings

Historical chart of Independent Advisor Alliance investment in Neurosense Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by Independent Advisor Alliance consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by Independent Advisor Alliance

Quarter filed Position value Share count Share price at filing
2026-03-31 $38k 50k 0.76

More positions owned by Independent Advisor Alliance

NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Ameris Ban (ABCB)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Spdr Series Trust State Street Spd (SPYG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Spdr Index Shs Fds State Street Spd (SPDW)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for Independent Advisor Alliance

Top funds holding Neurosense Therapeutics

Yorkville Advisors Global
Independent Advisor Alliance
UBS Group
Two Sigma Investments
Meitav Dash Investments
Gts Securities
Jane Street
Commonwealth Equity Services
Pnc Financial Services
Pathstone Holdings
Geode Capital Management
Creative Planning
Jones Financial Companies, L.L
SBI Securities

View all funds holding Neurosense Therapeutics